High performance liquid chromatography determination of cytochrome P450 1A and 2C activities in bovine liver microsomes

Veterinary Journal

Volumn 183, Issue 1, 2010, Pages 81-88

  Pegolo, Sara ^a   Merlanti, Roberta ^a   Giantin, Mery ^a   Dacasto, Mauro ^a   Montesissa, Clara ^a   Capolongo, Francesca ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Bovine; EROD; HPLC; Liver microsomes; TMH

Indexed keywords

ALPHA NAPHTHOFLAVONE; CYTOCHROME P450 1A; CYTOCHROME P450 2C; ETHOXYRESORUFIN DEETHYLASE; HYDROXYTOLBUTAMIDE; SULFAPHENAZOLE;

ACCURACY; ANIMAL CELL; ARTICLE; BEEF CATTLE; CALF (BOVINE); CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERMETHOD COMPARISON; LIVER MICROSOME; NONHUMAN; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; VEAL;

ANIMALS; ANIMALS, NEWBORN; CALIBRATION; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 ENZYME SYSTEM; KINETICS; MICROSOMES, LIVER; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY; SPECTROMETRY, FLUORESCENCE;

BOS; BOVINAE;

EID: 72249087024     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2008.08.006     Document Type: Article

References (35)

1. Bjornsson T.D., Callaghan J.T., Einolf H.J., Fischer V., Gan L., Grimm S., Kao J., King S.P., Miwa G., Ni L., Kumar G., MacLeod J., Obach R.S., Roberts S., Roe A., Shah A., Snikeris F., Sullivan J.T., Tweedie D., Vega J.M., Walsh J., and Wrighton S.A. The conduct of in vitro and in vivo drug-drug interaction studies: a pharmaceutical research and manufacturers of America (PhRMA) perspective. Drug Metabolism and Disposition 31 (2003) 815-832
2. Bourrìe M., Meunier V., Berger Y., and Fabre G. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes. The Journal of Pharmacology and Experimental Therapeutics 277 (1996) 321-332
3. Burke M., and Mayer R.T. Ethoxyresorufin: direct fluometric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylchloranthrene. Drug Metabolism and Disposition 2 (1974) 583-588
4. Cantiello M., Carletti M., Dacasto M., Martin P.G.P., Pineau T., Capolongo F., Gardini G., and Nebbia C. Cytochrome P450 inhibition profile in liver of veal calves administered a combination of 17(-estradiol, clenbuterol, and dexamethasone for growth-promoting purposes. Food and Chemical Toxicology 46 (2008) 2849-2855
5. Chauret N., Gauthier A., Martin J., and Nicoll-Griffith D.A. In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat and horse. Drug Metabolism and Disposition 25 (1997) 1130-1136
6. Elbarbry F., Wilby K., and Alcorn J. Validation of a HPLC method for the determination of p-nitrophenol hydroxylase activity in rat hepatic microsomes. Journal of Chromatography B 834 (2006) 199-203
7. Giantin M., Carletti M., Capolongo F., Pegolo S., Lopparelli R.M., Gusson F., Nebbia C., Cantiello M., Martin P., Pineau T., and Dacasto M. Effect of breed upon cytochrome P450 and phase II enzyme expression in cattle liver. Drug Metabolism and Disposition 36 (2008) 885-893
8. Greco W.R., and Hakala M.T. Evaluation of methods for estimating the dissociation constant of tight binding enzyme inhibitors. The Journal of Biological Chemistry 254 (1979) 12104-12109
9. Guengerich F.P. Comparison of catalytic selectivity of cytochrome P450 subfamily enzymes from different species. Chemico-Biological Interactions 106 (1997) 161-182
10. Hanioka N., Tatarazako N., Jinno H., Arizono K., and Ando M. Determination of cytochrome P4501A activities in mammalian liver microsomes by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B 744 (2000) 399-406
11. Hickman D., Wang J., Wang Y., and Unadkat J.D. Evaluation of the selectivity of in vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities. Drug Metabolism and Disposition 26 (1998) 207-215
12. Ioannides C., and Parke D.V. The cytochrome P450 I gene family of microsomal hemoproteins and their role in the metabolic activation of chemicals. Drug Metabolism Reviews 22 (1990) 1-85
13. Ioannides C. Effect of diet and nutrition on the expression of cytochrome P450. Xenobiotica 29 (1998) 109-154
14. Ioannides C. Cytochrome P450 expression in the liver of food-producing animals. Current Drug Metabolism 7 (2006) 335-348
15. Kaneko J.J., Harvey J.W., and Bruss M.L. Appendix VIII. Blood analyte reference values in large animals. In: Kaneko J.J., Harvey J.W., and Bruss M.L. (Eds). Clinical Biochemistry of Domestic Animals. fifth ed. (1997), Academic press, San Diego, CA 890-891
16. Kennedy S.W., Lorenzen A., James C.A., and Collins B.T. Ethoxyresorufin-O-deethylase and porphyrin analysis in chicken embryo hepatocyte cultures with a fluorescence multiwell plate reader. Analytical Biochemistry 211 (1993) 102-112
17. Lapis P., Pass G.J., McKinnon R.A., and Stupans I. Characterisation of tolbutamide hydroxylase activity in the common brushtail possum (Trichosurus vulpecula) and koala (Phascolarctos cinereus): inhibition by the Eucalyptus terpene 1,8-cineole. Comparative Biochemistry and Physiology Part C 127 (2000) 351-357
18. Leclercq I., Desager J.P., Vandenplas C., and Horsmans Y. Fast determination of low-level cytochrome P450 1A1 activity by high-performance liquid chromatography with fluorescence or visible absorbance detection. Journal of Chromatography B 681 (1996) 227-232
19. Lowry O.H., Rosenbrough N.Y., Farr A.L., and Randall R.Y. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
20. Miners J.O., Smith K.J., Robson R.A., McManus M.E., Veronese M.E., and Birkett D.J. Tolbutamide hydroxylation by human liver microsomes. Biochemical Pharmacology 37 (1988) 1137-1144
21. Miners J.O., and Birkett D.J. Cytochome P4502C9: an enzyme of major importance in human drug metabolism. British Journal of Clinical Pharmacology 45 (1998) 525-538
22. Nebbia C. Biotransformation enzymes as determinants of xenobiotic toxicity in domestic animals. The Veterinary Journal 161 (2001) 238-252
23. Nebbia C., Dacasto M., Rossetto Giaccherino A., Giuliano Albo A., and Carletti M. Comparative expression of liver cytochrome P450-dependent monooxygenases in the horse and in other agricultural and laboratory species. The Veterinary Journal 165 (2003) 53-64
24. Palamanda J., Feng W.W., Lin C.C., and Nomeir A.A. Stimulation of tolbutamide hydroxylation by acetone and acetonitrile in human liver microsomes and in a cytochrome P-450 2C9-reconstituted system. Drug Metabolism and Disposition 28 (2000) 38-43
25. Parkinson A. Biotransformation of xenobiotics. In: Klaassen C.D. (Ed). Casarett and Doull's Toxicology: The Basic Science of Poisons (1996), McGraw-Hill, New York 113-186
26. Pohl R.J., and Fouts J.R. A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Analytical Biochemistry 107 (1980) 150-155
27. Rahman A., Korzekwa K.R., Grogan J., Gonzalez F.J., and Harris J.W. Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8. Cancer Research 54 (1994) 5543-5546
28. Sivapathasundaram S., Magnisali P., Coldham N.G., Howells L.C., Sauer M.J., and Ioannides C. A study of the expression of the xenobiotic-metabolizing cytochrome P450 proteins and of testosterone metabolism in bovine liver. Biochemical Pharmacology 62 (2001) 635-645
29. Szotáková B., Baliharová V., Lamka J., Nožinová E., Wsól V., VelíK J., Machala M., Nec J., Soucek P., Šusová S., and Skálová L. Comparison of in vitro activities of biotransformation enzymes in pig, cattle, goat and sheep. Research in Veterinary Science 76 (2004) 43-51
30. Tang C., Shou M., and Rodrigues D. Substrate-dependent effect of acetonitrile on human liver microsomal cytochrome P450 2C9 (CYP2C9) activity. Drug Metabolism and Disposition 28 (2000) 567-572
31. Walsky R.L., and Obach R.S. Validated assays for human cytochrome P450 activities. Drug Metabolism and Disposition 32 (2004) 647-660
32. Weaver R.J., Dickins M., and Burke D. Hydroxylation of the antimalarial drug 58C80 by CYP2C9 in human liver microsomes: comparison with mephenytoin and tolbutamide hydroxylations. Biochemical Pharmacology 49 (1995) 997-1004
33. Yuan R., Madani S., Wei X., Reynolds K., and Huang S. Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions. Drug Metabolism and Disposition 30 (2002) 1311-1319
34. Zweers-Zeilmaker W.M., Horbach G.J., and Witkamp R.F. Differential inhibitory effects of phenytoin, diclofenac, phenylbutazone and a series of sulfonamides on hepatic cytochrome P4502C activity in vitro, and correlation with some molecular descriptors in the dwarf goat (Caprus hircus aegagrus). Xenobiotica 27 (1997) 769-780
35. Zweers-Zeilmaker W.M., Horbach G.J., and Witkamp R.F. Effects of non steroidal anti-inflammatory drugs and sulfonamides on hepatic cytochrome P4502C activity in vitro in goats and cattle. Journal of Veterinary Pharmacology and Therapeutics 21 (1998) 154-157